A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z

Recent news on Zaditor


Allergy agony  -  25 May 2007
Napa Valley Register,Peter Corbet-Owen, a pharmacist at Rite Aid on Imola Avenue, said he is filling more than the usual number of prescriptions for Zaditor and Claritin.

Spring allergies are more than meets the eye  -  May 5, 2007
Tooele Transcript-Bulletin,New as of this year, a prescription eye allergy drop called Zaditor has just been released to be sold OTC. Bausch and Lomb has capitalized on this and has

The Eyes Have It!  -  Apr 28, 2007
About - News & Issues,And since Zaditor® is OTC but not generic, you can bet it has a hefty price tag attached. And the consumer will now be paying that price - not the insurance

Dropping In on Eye Allergy Relief  -  Apr 30, 2007
FOX NewsAnother type of mast cell stabilizer, ketotifen eye drops, sold under brand names Zaditor and Alaway, have recently been approved by the FDA and are now

Preventative Steps May Ward Off Allergies  -  Mar 27, 2007
Boston Channel.com,Zaditor is an eye drop that is now available over the counter. "It treats the itchiness the wateriness -- but with the regular use will actually prevent the

Preventative Steps May Ward Off Allergies  -  Mar 27, 2007
Boston Channel.com,Zaditor is an eye drop that is now available over the counter. "It treats the symptoms while they're there -- the itchiness the wateriness -- but with the

Mergers, Acquisitions, etc.  -  Feb 16, 2007
OSN SuperSite (subscription),Under the transaction, Bausch & Lomb will take control of Alaway (ketotifen fumarate 0.025%), the OTC equivalent to Zaditor (ketotifen fumarate 0.025%,

Bausch & Lomb buys Alimera product line  -  Dec 20, 2006
BusinessWeekThe companies said the product is similar to Zaditor, a prescription product that Novartis is turning into an over-the-counter version.

B&L buys allergy business  -  Dec 20, 2006
Rochester Business Journal,The solution contains the same active ingredient and strength and is shown to be therapeutically equivalent to Zaditor, a prescription product being

Alimera Sciences and Bausch & Lomb Announce Transaction for Alaway ...  -  Dec 20, 2006
dBusinessNews Atlanta (press release),Alaway contains the same active ingredient and strength and is shown to be therapeutically equivalent to Zaditor™, a prescription product being switched to

Bausch & Lomb Buys Alimera Product Line  -  Dec 20, 2006
Forbes,The companies said the product is similar to Zaditor, a prescription product that Novartis is turning into an over-the-counter version. ...

Alimera Sciences and Bausch & Lomb Announce Transaction for Alaway ...  -  Dec 20, 2006
dBusinessNews Atlanta (press release),Alaway contains the same active ingredient and strength and is shown to be therapeutically equivalent to Zaditor™, a prescription product being switched to ...

OTC Ketotifen Fumarate Ophthalmic Solution Approved  -  Dec 5, 2006
Facts and Comparisons,The medication is generically equivalent to Zaditor by Novartis and is expected to be available to consumers for the spring 2007 allergy season.

B&L buys allergy business  -  Dec 20, 2006
Rochester Business Journal,The solution contains the same active ingredient and strength and is shown to be therapeutically equivalent to Zaditor, a prescription product being switched ...

Going To Market:: Alimera Sciences Wins FDA Approval To Sell Eye ...  -  Dec 5, 2006
Local Tech Wire,...a new drug application for Alaway earlier this year, saying a clinical study had proven the drug was the bioequivalent of a drug from Novartis called Zaditor. ...

Alimera's Alaway approved for OTC sales  -  Dec 5, 2006
United Press InternationalThe company initially filed the new drug application for Alaway in February after showing it was bioequivalent to Novartis's Zaditor.

Alimera Sciences Receives FDA Approval To Market Alaway(TM) OTC ...  -  Dec 6, 2006
Medical News Today (press release),NDA for Alaway(TM) in February of this year after completing a successful clinical study that showed it to be bioequivalent to Novartis' Zaditor(R) (ketotifen ...

Novartis' Zaditor approved by FDA for over-the-counter relief from ...  Oct 20, 2006
ZURICH (AFX) - Novartis AG announced that the US Food and Drug Administration (FDA) has approved Zaditor ophthalmic solution, indicated for the temporary ... -Forbes, Novartis: FDA Oks Zaditor for over-the-counter use  Oct 20, 2006
Novartis AG (NVS) said the Food and Drug Administration approved Zaditor for over-the-counter use to relieve itchy eyes due to allergies. ... -MarketWatch Novartis' Zaditor approved for OTC sales  Oct 20, 2006
20 (UPI) -- Novartis said Friday the US Food and Drug Administration approved the itchy-eyes treatment Zaditor for over-the-counter sales. ... -United Press International Novartis Receives Approval For Zaditor As OTC Medication For Itchy ...  Oct 20, 2006
...(NVS | charts | news | PowerRating) announced that FDA approved Zaditor for the temporary ... Earlier, Zaditor was approved as a prescription drug in 1999. ... -Trading Markets, FDA Approves Prescription Zaditor(R) For Over-The-Counter Relief ...  Oct 21, 2006
Novartis Pharmaceuticals Corporation today announced that the US Food and Drug Administration (FDA) has approved prescription Zaditor(R) (ketotifen fumarate ... -Medical News Today (press release), FDA Approves Prescription Zaditor(R) for Over-The-Counter Relief ...  Oct 20, 2006
...* Zaditor Provides Up to 12 Hours of Continuous Itch ... In addition, Zaditor is the first OTC eye itch medication safe for use in children as young as three. ... -PR Newswire (press release), FDA Approves Prescription Zaditor(R) for Over-The-Counter Relief ...  Oct 20, 2006
Novartis Pharmaceuticals Corporation today announced that the US Food and Drug Administration (FDA) has approved prescription Zaditor(R) (ketotifen fumarate ... -PR Newswire (press release), FDA Approves Zaditor for Over-the-Counter Use  Oct 20, 2006
The Food and Drug Administration approved the prescription drug Zaditor for over-the-counter use for temporary prevention of itchy eyes. ... -Business New Jersey (subscription), Zaditor® - over-the-counter drug for itchy eyes  Oct 22, 2006
According to Novartis Pharmaceuticals Corporation, Zaditor® (ketotifen fumarate ophthalmic solution 0.025%), prescribed for the temporary prevention of itchy ... -MedIndia, Market Report -- In Play (NVS)  Oct 20, 2006
Novartis AG announces FDA approves prescription Zaditor for OTC relief from itchy eyes Co announces that the FDA has approved prescription Zaditor (ketotifen ... -MSN Money FDA Approves Novartis OTC Itch Drug  Oct 20, 2006
...unit of Swiss drug maker Novartis AG, said Friday that the Food and Drug Administration approved an over-the-counter version of its itchy eye treatment Zaditor ... -Houston Chronicle, Foro de Shell Security - Seguridad informática  Oct 27, 2006
...aggressiveness. However, some subtypes of yohimbine high-grade lymphomas are characterized by small cell morph zaditor logy. For ... -Shell Security, S*BIO Appoints Joy Zhu Senior Vice President of Global Clinical ...  Oct 27, 2006
...global studies from Phase 1 to Phase 3. At Novartis, Dr. Zhu was responsible for two successful NDA submissions for ophthalmic drugs (Zaditor® and Rescula ... -Yahoo! News (press release) Going To Market:: Alimera Sciences Wins FDA Approval To Sell Eye ...  -  Dec 5, 2006
Local Tech Wire,...drug application for Alaway earlier this year, saying a clinical study had proven the drug was the bioequivalent of a drug from Novartis called Zaditor.

OTC Ketotifen Fumarate Ophthalmic Solution Approved  -  Dec 5, 2006
Facts and Comparisons,The medication is generically equivalent to Zaditor by Novartis and is expected to be available to consumers for the spring 2007 allergy season.

Alimera's Alaway approved for OTC sales  -  Dec 5, 2006
United Press InternationalThe company initially filed the new drug application for Alaway in February after showing it was bioequivalent to Novartis's Zaditor.

Alimera Sciences Receives FDA Approval To Market Alaway(TM) OTC ...  -  Dec 6, 2006
Medical News Today (press release),...after completing a successful clinical study that showed it to be bioequivalent to Novartis' Zaditor(R) (ketotifen fumarate ophthalmic solution 0.025%).


This site is for informational purposes only--it does not offer medical advice or sell health products. If you need assistance, contact your physician or healthcare professional